Skip to main content

EU Awards Consortium $3.6M to Study Genetic Basis of Breast, Prostate Cancer

NEW YORK, Dec. 19 (GenomeWeb News) - The European Union has awarded Polygene, a research consortium led by Iceland Genomics, a 3 million ($3.6 million) grant to study the inherited risk of breast and prostate cancer, the company said today.


The consortium will study 6,000 patients and controls to discover new genetic causes of breast and prostate cancer, making it one of the largest cancer genetics studies performed to date.


The consortium includes Iceland Genomics, Bioinformatics ApS of Denmark, the Department of Statistics at the University of Oxford, UK, and the Radboud University Nijmegen Medical Center of the Netherlands.


The results of the project are expected by the end of 2008.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.